David Jobes describes the Collaborative Assessment and Management of Suicidality framework, a problem-focused treatment, designed to provide a sense of agency to patients considering suicide.
Your patients may be using it at home (even if they’re not telling you). We look at whether transcranial direct current stimulation (tDCS) works and how it differs from transcranial magnetic stimulation (TMS).
Listen to the full text of the issue read aloud by Gregory Malzberg, MD. In this issue, David Jobes shows us how to empower patients while collaboratively assessing suicidality. Eight ways to treat OCD when SSRIs fail. Antipsychotic dosing in mania vs. schizophrenia, and all you need to know about a popular at-home treatment for depression: Transcranial direct stimulation (tDCS).
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three...